FDA Approves First Drug for Sinusitis With Nasal Polyps, Dupixent (Dupilumab)

THURSDAY, June 27, 2019 -- In what specialists say could be a turning point in care, the U.S. Food and Drug Administration on Wednesday approved the first drug to treat chronic sinusitis that involves the growth of polyps within the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news